Conditions: Subacromial Impingement; Subacromial Impingement Syndrome
Interventions: Drug: Ketorolac Tromethamine; Drug: Methylprednisolone Acetate
Sponsor: The University of Texas Medical Branch, Galveston
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Osteoarthritis, Knee
Interventions: Other: OM1 Dell Shared Decision Making Tool; Other: Education material from OM1 Dell Shared Decision Making Tool
Sponsor: University of Texas at Austin
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Compartment Syndrome of Leg
Intervention: Drug: OnabotulinumtoxinA Injection
Sponsor: University of Wisconsin, Madison
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Acute Upper Extremity Trauma
Interventions: Other: Minimally Processed Human Umbilical Cord Membrane; Other: Standard Surgical Procedures
Sponsor: Axogen Corporation
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Osteoarthritis, Hip
Interventions: Drug: isobaric bupivacaine; Drug: hyperbaric bupivacaine; Drug: isobaric mepivacaine
Sponsor: Thomas Jefferson University
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Disc Degeneration;Cervical
Intervention: Procedure: Anterior cervical discectomy and fusion
Sponsor: SeaSpine, Inc.
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Pain
Interventions: Drug: Nebulized Sub-dissociative Dose Ketamine at either 0.75 mg/kg; Drug: Nebulized Sub-dissociative Dose Ketamine at 1 mg/kg; Drug: Nebulized Sub-dissociative Dose Ketamine at 1.5 mg/kg.
Sponsor: Antonios Likourezos
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Role of Sex Hormones Along the Neuromechanical Axis
Intervention: Device: Transcranial Magnetic Stimulation Device
Sponsors: University of Texas Southwestern Medical Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Conditions: Pain, Chronic; Prescription Drug Abuse (Not Dependent)
Intervention:
Sponsor: University of Florida
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Conditions: Osteo Arthritis Knee; Degenerative Joint Disease of Knee
Interventions: Biological: Autologous Adipose-Derived SVF (Stromal Vascular Fraction); Drug: Placebo
Sponsor: Mayo Clinic
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days




